FORMYCON AG (FYB.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:FYB - DE000A1EWVY8 - Common Stock
23.7 EUR
-0.3 (-1.25%)
We assign a fundamental rating of 3 out of 10 to FYB. FYB was compared to 86 industry peers in the Biotechnology industry. FYB may be in some trouble as it scores bad on both profitability and health. FYB is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year FYB has reported negative net income.
- FYB had a positive operating cash flow in the past year.
- In multiple years FYB reported negative net income over the last 5 years.
- In the past 5 years FYB always reported negative operating cash flow.
1.2 Ratios
- FYB has a Return On Assets (-22.86%) which is in line with its industry peers.
- FYB's Return On Equity of -41.58% is fine compared to the rest of the industry. FYB outperforms 61.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -22.86% | ||
| ROE | -41.58% | ||
| ROIC | N/A |
ROA(3y)-1.19%
ROA(5y)-6.14%
ROE(3y)-0.68%
ROE(5y)-7.18%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for FYB so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- FYB does not have a ROIC to compare to the WACC, probably because it is not profitable.
- FYB has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for FYB has been increased compared to 5 years ago.
- The debt/assets ratio for FYB has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 0.50, we must say that FYB is in the distress zone and has some risk of bankruptcy.
- FYB has a Altman-Z score (0.50) which is comparable to the rest of the industry.
- FYB has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
- FYB has a Debt to Equity ratio of 0.02. This is in the better half of the industry: FYB outperforms 75.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.5 |
ROIC/WACCN/A
WACC7.27%
2.3 Liquidity
- FYB has a Current Ratio of 1.54. This is a normal value and indicates that FYB is financially healthy and should not expect problems in meeting its short term obligations.
- FYB has a Current ratio (1.54) which is comparable to the rest of the industry.
- FYB has a Quick Ratio of 1.51. This is a normal value and indicates that FYB is financially healthy and should not expect problems in meeting its short term obligations.
- FYB has a Quick ratio of 1.51. This is comparable to the rest of the industry: FYB outperforms 45.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.54 | ||
| Quick Ratio | 1.51 |
3. Growth
3.1 Past
- The earnings per share for FYB have decreased strongly by -339.98% in the last year.
- FYB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.84%.
- FYB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.48% yearly.
EPS 1Y (TTM)-339.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-425.42%
Revenue 1Y (TTM)-14.84%
Revenue growth 3Y23.92%
Revenue growth 5Y15.48%
Sales Q2Q%0.03%
3.2 Future
- FYB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 49.56% yearly.
- The Revenue is expected to grow by 21.52% on average over the next years. This is a very strong growth
EPS Next Y-86.84%
EPS Next 2Y31.17%
EPS Next 3Y49.56%
EPS Next 5YN/A
Revenue Next Year-8%
Revenue Next 2Y22.8%
Revenue Next 3Y31.02%
Revenue Next 5Y21.52%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- FYB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year FYB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- 96.51% of the companies in the same industry are more expensive than FYB, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.55 |
4.3 Compensation for Growth
- FYB's earnings are expected to grow with 49.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.17%
EPS Next 3Y49.56%
5. Dividend
5.1 Amount
- FYB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FORMYCON AG / FYB.DE FAQ
What is the ChartMill fundamental rating of FORMYCON AG (FYB.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to FYB.DE.
What is the valuation status of FORMYCON AG (FYB.DE) stock?
ChartMill assigns a valuation rating of 2 / 10 to FORMYCON AG (FYB.DE). This can be considered as Overvalued.
What is the profitability of FYB stock?
FORMYCON AG (FYB.DE) has a profitability rating of 1 / 10.
How financially healthy is FORMYCON AG?
The financial health rating of FORMYCON AG (FYB.DE) is 3 / 10.
Can you provide the expected EPS growth for FYB stock?
The Earnings per Share (EPS) of FORMYCON AG (FYB.DE) is expected to decline by -86.84% in the next year.